IRIS - Res&Arch Institutional Research Information System - Research & Archive

VERSO, Melina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.841
AS - Asia 1.303
EU - Europa 1.297
SA - Sud America 256
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 38
OC - Oceania 4
Totale 4.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.785
SG - Singapore 695
IT - Italia 242
IE - Irlanda 238
BR - Brasile 200
UA - Ucraina 194
RU - Federazione Russa 186
CN - Cina 148
HK - Hong Kong 139
VN - Vietnam 113
DE - Germania 95
FR - Francia 78
SE - Svezia 75
FI - Finlandia 72
TR - Turchia 48
GB - Regno Unito 45
CA - Canada 31
BD - Bangladesh 29
IN - India 29
KR - Corea 21
AT - Austria 16
IQ - Iraq 15
AR - Argentina 14
BE - Belgio 14
VE - Venezuela 11
NL - Olanda 10
PL - Polonia 10
ZA - Sudafrica 10
PK - Pakistan 9
UZ - Uzbekistan 9
EC - Ecuador 8
MX - Messico 8
CO - Colombia 7
JP - Giappone 7
PH - Filippine 7
JO - Giordania 6
KE - Kenya 6
MA - Marocco 6
CH - Svizzera 5
CL - Cile 4
ES - Italia 4
ID - Indonesia 4
LB - Libano 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
LT - Lituania 3
NG - Nigeria 3
SV - El Salvador 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
AU - Australia 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
LY - Libia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TO - Tonga 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.744
Salva come PNG Salva come JPEG
Città #
Singapore 490
Dublin 233
Chandler 215
San Jose 151
Hong Kong 137
San Mateo 133
Ashburn 112
Jacksonville 111
Perugia 90
Santa Clara 73
Altamura 70
Boardman 67
Ann Arbor 66
Moscow 63
Medford 61
Princeton 60
Lawrence 56
Lauterbourg 54
Wilmington 46
Andover 41
Izmir 36
Munich 34
Los Angeles 32
Ho Chi Minh City 31
Des Moines 27
Dong Ket 27
New York 25
Beijing 23
The Dalles 22
Seoul 21
Hanoi 20
Saint Petersburg 17
Helsinki 16
Norwalk 16
São Paulo 16
Brussels 14
San Paolo di Civitate 13
Redmond 11
Turku 11
Brooklyn 9
Montreal 9
Rio de Janeiro 9
Dallas 8
Rome 8
Chennai 7
Chicago 7
Johannesburg 7
Piscataway 7
Redwood City 7
Seattle 7
Amman 6
Atlanta 6
Belo Horizonte 6
Caracas 6
New Orleans 6
Nuremberg 6
Stockholm 6
Tokyo 6
Toronto 6
Vienna 6
Warsaw 6
Woodbridge 6
Baghdad 5
Buffalo 5
Denver 5
Haiphong 5
Houston 5
London 5
Nairobi 5
Orem 5
Shanghai 5
Amsterdam 4
Bologna 4
Boston 4
Brasília 4
Charlotte 4
Da Nang 4
Delhi 4
Falkenstein 4
Fortaleza 4
Goslar 4
Guangzhou 4
Lima 4
Manchester 4
Miami 4
Mumbai 4
Parabiago 4
Philadelphia 4
Phoenix 4
Porto Alegre 4
San Francisco 4
Vancouver 4
Bogotá 3
Buenos Aires 3
Casablanca 3
Dhaka 3
Frankfurt am Main 3
Guayaquil 3
Istanbul 3
Kocaeli 3
Totale 3.051
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cerebral vein and sinus thrombosis. 125
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 110
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 109
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 108
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 106
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 105
Risk factors for venous thromboembolism in the elderly: results of the master registry. 105
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 105
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 105
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 103
A prospective study on survival in cancer patients with and without venous thromboembolism. 102
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 101
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 100
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 95
Apixaban for the treatment of venous thromboembolism associated with cancer 95
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry 93
Epidemiology of cerebral vein and sinus thrombosis 93
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 93
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. 91
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 91
Do antiangiogenics promote clot instability? Data from the TESEO prospective registry and Caravaggio clinical trial. 87
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter-related deep vein thrombosis in a child with acute lymphoblastic leukemia. 85
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 84
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 83
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 83
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). 78
Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism. 76
A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry. 76
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma 76
Do italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses included in the ''Master'' Registry. 75
Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus 71
Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism 70
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials? 69
Risk factors of catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. 69
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. 68
Building effective prophylaxis of deep vein thrombosis in the outpatient setting. Blood Coagul Fibrinolysis. 68
Management of venous thromboembolism in patients with cancer. 68
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study 68
Thromboprophylaxis during chemotherapy in patients with advanced cancer. 67
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. 67
New oral anticoagulants and their management in dental practice 67
Targeted anti-cancer agents and risk of venous thromboembolism 64
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 63
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer 62
Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry. 61
Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life 61
Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the protecht and topic-2 studies. 60
Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER Registry. 60
PL-21 New and old anticoagulants in cancer. 59
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 58
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer 58
Thrombosis and cancer: clinical relevance of a dangerous liaison. 57
Thromboprophylaxis during chemotherapy after advanced cancer. 57
Therapy insight:venous-catheter-related thrombosis in cancer patients 57
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. 54
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 53
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 53
Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter 51
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry 49
The MASTER registry on venous thromboembolism: description of the study cohort. 49
Prophylaxis against venous thromboembolism in patients with cancer [3] 49
To the editor: The effect of low-molecular-weight heparin in cancer patients: The mirror image of survival? 47
New strategies of VTE prevention in cancer patients. 46
Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence 35
Totale 4.853
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022411 0 0 8 13 24 4 5 161 6 45 70 75
2022/2023798 67 189 15 44 49 89 0 28 283 1 27 6
2023/2024228 18 25 24 3 3 0 39 9 7 14 50 36
2024/2025827 0 68 1 39 126 39 52 41 153 60 175 73
2025/20261.550 128 102 95 159 224 126 288 90 146 117 45 30
2026/2027130 29 54 47 0 0 0 0 0 0 0 0 0
Totale 4.853